| Dr Keitha Ann Covalla, OD | |
|
2001 S Glenburnie Rd, New Bern, NC 28562-5228 | |
| (252) 633-6900 | |
| (252) 633-6754 |
| Full Name | Dr Keitha Ann Covalla |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 23 Years |
| Location | 2001 S Glenburnie Rd, New Bern, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124023221 | NPI | - | NPPES |
| 093HK | Other | NC | BCBSNC PIN |
| 89093HK | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1829 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Singleton Vision Center | 5193780054 | 3 |
| Lane Optometry Pllc | 7517100647 | 5 |
News Archive
A new microRNA (miRNA) screening assay detected the majority of early-stage colorectal cancers with good specificity and sensitivity. Our test has the potential to be safe, cheap, robust, accurate and of little or no inconvenience to the individual, and could, therefore, easily be integrated into national screening programs as part of an annual checkup,said Søren Jensby Nielsen, Ph.D., scientific manager, Diagnostic Product Development, Exiqon A/S
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved JUVISYNC(sitagliptin and simvastatin), a new treatment for type 2 diabetes that combines the glucose-lowering medication sitagliptin, the active component of JANUVIA (sitagliptin), with the cholesterol-lowering medication ZOCOR.
Scientists may have made a giant leap in fighting the biggest threat to human health by using supercomputing to keep pace with the impressive ability of diseases to evolve.
Spheris, a leading global provider of clinical documentation technology and services, today announced that it has entered into an agreement under which MedQuist Inc. and CBay Inc., portfolio companies of CBaySystems Holdings Ltd. and leading providers of medical transcription software and services, have agreed to purchase substantially all of Spheris' assets pursuant to a transaction that is to be implemented under Section 363 of the United States Bankruptcy Code.
› Verified 4 days ago
| Provider Name | Singleton Vision Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1407830540 PECOS PAC ID: 5193780054 Enrollment ID: O20041119001087 |
News Archive
A new microRNA (miRNA) screening assay detected the majority of early-stage colorectal cancers with good specificity and sensitivity. Our test has the potential to be safe, cheap, robust, accurate and of little or no inconvenience to the individual, and could, therefore, easily be integrated into national screening programs as part of an annual checkup,said Søren Jensby Nielsen, Ph.D., scientific manager, Diagnostic Product Development, Exiqon A/S
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved JUVISYNC(sitagliptin and simvastatin), a new treatment for type 2 diabetes that combines the glucose-lowering medication sitagliptin, the active component of JANUVIA (sitagliptin), with the cholesterol-lowering medication ZOCOR.
Scientists may have made a giant leap in fighting the biggest threat to human health by using supercomputing to keep pace with the impressive ability of diseases to evolve.
Spheris, a leading global provider of clinical documentation technology and services, today announced that it has entered into an agreement under which MedQuist Inc. and CBay Inc., portfolio companies of CBaySystems Holdings Ltd. and leading providers of medical transcription software and services, have agreed to purchase substantially all of Spheris' assets pursuant to a transaction that is to be implemented under Section 363 of the United States Bankruptcy Code.
› Verified 4 days ago
| Provider Name | Lane Optometry Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1356628283 PECOS PAC ID: 7517100647 Enrollment ID: O20130821000452 |
News Archive
A new microRNA (miRNA) screening assay detected the majority of early-stage colorectal cancers with good specificity and sensitivity. Our test has the potential to be safe, cheap, robust, accurate and of little or no inconvenience to the individual, and could, therefore, easily be integrated into national screening programs as part of an annual checkup,said Søren Jensby Nielsen, Ph.D., scientific manager, Diagnostic Product Development, Exiqon A/S
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved JUVISYNC(sitagliptin and simvastatin), a new treatment for type 2 diabetes that combines the glucose-lowering medication sitagliptin, the active component of JANUVIA (sitagliptin), with the cholesterol-lowering medication ZOCOR.
Scientists may have made a giant leap in fighting the biggest threat to human health by using supercomputing to keep pace with the impressive ability of diseases to evolve.
Spheris, a leading global provider of clinical documentation technology and services, today announced that it has entered into an agreement under which MedQuist Inc. and CBay Inc., portfolio companies of CBaySystems Holdings Ltd. and leading providers of medical transcription software and services, have agreed to purchase substantially all of Spheris' assets pursuant to a transaction that is to be implemented under Section 363 of the United States Bankruptcy Code.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Keitha Ann Covalla, OD 2001 S Glenburnie Rd, New Bern, NC 28562-5228 Ph: (252) 633-6900 | Dr Keitha Ann Covalla, OD 2001 S Glenburnie Rd, New Bern, NC 28562-5228 Ph: (252) 633-6900 |
News Archive
A new microRNA (miRNA) screening assay detected the majority of early-stage colorectal cancers with good specificity and sensitivity. Our test has the potential to be safe, cheap, robust, accurate and of little or no inconvenience to the individual, and could, therefore, easily be integrated into national screening programs as part of an annual checkup,said Søren Jensby Nielsen, Ph.D., scientific manager, Diagnostic Product Development, Exiqon A/S
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved JUVISYNC(sitagliptin and simvastatin), a new treatment for type 2 diabetes that combines the glucose-lowering medication sitagliptin, the active component of JANUVIA (sitagliptin), with the cholesterol-lowering medication ZOCOR.
Scientists may have made a giant leap in fighting the biggest threat to human health by using supercomputing to keep pace with the impressive ability of diseases to evolve.
Spheris, a leading global provider of clinical documentation technology and services, today announced that it has entered into an agreement under which MedQuist Inc. and CBay Inc., portfolio companies of CBaySystems Holdings Ltd. and leading providers of medical transcription software and services, have agreed to purchase substantially all of Spheris' assets pursuant to a transaction that is to be implemented under Section 363 of the United States Bankruptcy Code.
› Verified 4 days ago
Mark Emerson Leary, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2805 Village Way, New Bern, NC 28562 Phone: 252-633-0016 Fax: 252-636-3895 | |
Craven Optometric Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3005 Dr Martin Luther King Jr Blvd, New Bern, NC 28562 Phone: 252-633-0651 Fax: 252-514-9419 | |
Christensen Eye Care Od Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3005 Dr Martin Luther King Jr Blvd, New Bern, NC 28562 Phone: 252-633-0651 Fax: 252-514-9419 | |
Coastal Eye Clinic, Pa Optometrist Medicare: Medicare Enrolled Practice Location: 802 Mccarthy Blvd, New Bern, NC 28562 Phone: 252-633-4183 Fax: 252-636-1674 | |
Dr. Adrienne Pak Earle, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3000 Trent Rd, New Bern, NC 28562 Phone: 252-637-2921 Fax: 252-637-1863 | |
New Bern Family Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 2805 Village Way, New Bern, NC 28562 Phone: 252-633-0016 Fax: 252-636-3895 |